Andrew K.P. Taggart
Novartis (Switzerland)(CH)Novartis (China)(CN)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Cholesterol and Lipid Metabolism, Lipid metabolism and biosynthesis
Most-Cited Works
- → (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G(2005)640 cited
- → Est1p As a Cell Cycle-Regulated Activator of Telomere-Bound Telomerase(2002)352 cited
- → Role of GPR81 in lactate-mediated reduction of adipose lipolysis(2008)286 cited
- → Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib(2010)236 cited
- → Cell cycle-dependent regulation of yeast telomerase by Ku(2004)218 cited
- → The role of the Mre11-Rad50-Xrs2 complex in telomerase- mediated lengthening of Saccharomyces cerevisiae telomeres(2001)176 cited
- → The TATA-binding protein and associated factors are components of pol III transcription factor TFIIIB(1992)156 cited
- → Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression(2012)126 cited
- → 3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice(2008)93 cited
- → Dimerization of the TATA Binding Protein(1995)91 cited